We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+38%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$30.4B
AUM Growth
+$7.6B
Cap. Flow
+$167M
Cap. Flow %
0.55%
Top 10 Hldgs %
34%
Holding
622
New
73
Increased
196
Reduced
171
Closed
128

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$401M
2
SHAK icon
Shake Shack
SHAK
+$141M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$121M
4
DDOG icon
Datadog
DDOG
+$98.1M
5
LOW icon
Lowe's Companies
LOW
+$92.2M

Sector Composition

Rank Sector Weight
1 Technology 33.43%
2 Healthcare 21.84%
3 Consumer Discretionary 15%
4 Communication Services 9.98%
5 Financials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
376
Johnson Controls International
JCI
$85.1B
$709K ﹤0.01%
20,761
GPRK icon
377
GeoPark
GPRK
$609M
$685K ﹤0.01%
69,944
+66,271
+1,804% +$595K
MRTX
378
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$685K ﹤0.01%
6,000
-3,000
-33% -$291K
PLD icon
379
Prologis
PLD
$136B
$682K ﹤0.01%
7,305
EDU icon
380
New Oriental
EDU
$9.32B
$677K ﹤0.01%
5,200
-98,423
-95% -$12M
BNTX icon
381
BioNTech
BNTX
$23.5B
$667K ﹤0.01%
+10,000
New +$499K
PRVB
382
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$635K ﹤0.01%
45,000
+38,000
+543% +$480K
AFYA icon
383
Afya
AFYA
$1.35B
$615K ﹤0.01%
26,253
-13,500
-34% -$277K
ACN icon
384
Accenture
ACN
$106B
$614K ﹤0.01%
2,861
+250
+10% +$47.3K
LEGN icon
385
Legend Biotech
LEGN
$3.65B
$608K ﹤0.01%
+14,296
New +$559K
CSTL icon
386
Castle Biosciences
CSTL
$742M
$603K ﹤0.01%
16,000
HIG icon
387
Hartford Financial Services
HIG
$39.9B
$592K ﹤0.01%
15,349
ENV
388
DELISTED
ENVESTNET, INC.
ENV
$574K ﹤0.01%
7,808
-2,206
-22% -$144K
ALLE icon
389
Allegion
ALLE
$13.5B
$572K ﹤0.01%
5,600
HUBB icon
390
Hubbell
HUBB
$24.4B
$568K ﹤0.01%
4,530
+4,414
+3,805% +$538K
RNAM
391
DELISTED
Avidity Biosciences
RNAM
$565K ﹤0.01%
+20,000
New +$577K
ONC
392
BeOne Medicines Ltd
ONC
$33.9B
$565K ﹤0.01%
+3,000
New +$488K
ALLO icon
393
Allogene Therapeutics
ALLO
$625M
$557K ﹤0.01%
+13,000
New +$470K
EA icon
394
Electronic Arts
EA
$52.7B
$549K ﹤0.01%
4,159
+647
+18% +$76.4K
KALA icon
395
KALA BIO
KALA
$12.5M
$526K ﹤0.01%
+20
New +$567K
DOW icon
396
Dow Inc
DOW
$22B
$523K ﹤0.01%
12,828
+4,613
+56% +$169K
ADVM
397
DELISTED
Adverum Biotechnologies
ADVM
$522K ﹤0.01%
+2,500
New +$443K
INCY icon
398
Incyte
INCY
$25.8B
$520K ﹤0.01%
+5,000
New +$482K
OKE icon
399
Oneok
OKE
$56.7B
$518K ﹤0.01%
15,600
AMRN
400
Amarin Corp
AMRN
$297M
$498K ﹤0.01%
3,600
-400
-10% -$55K

Similar funds

Fred Alger Management's Q2 2020 Portfolio in Review

As of Q2 2020, Fred Alger Management held 622 positions worth $30.4B, up 33% from $22.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Fred Alger Management's Q2 2020 filing shows 73 new, 196 increased, 171 reduced and 128 closed positions. Its largest new stake was Datadog: 1,611,567 shares worth $140M. The largest sale was Microsoft, an estimated $184M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fred Alger Management's largest Q2 2020 buy was Datadog: 1,611,567 shares worth $140M.
  • Fred Alger Management added most to T-Mobile US in Q2 2020, an estimated $401M increase.
  • Fred Alger Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $184M.
  • Fred Alger Management fully exited Raytheon Company in Q2 2020, selling an estimated $46M.
  • Fred Alger Management's ten largest holdings make up 34% of its $30.4B portfolio in Q2 2020.
  • Fred Alger Management opened 73 new positions and closed 128 in Q2 2020.
  • Fred Alger Management's portfolio value rose 33% quarter-over-quarter to $30.4B.

Based on Fred Alger Management's 13F filing for Q2 2020, filed 14 Aug 2020.